Condition: Dysphonia · Connective Tissue Disease · Vasculitis · Sponsor: University Hospital, Brest
The goal of this multicenter retrospective observational study is to provide an inventory of the specific and non specific cord vocal lesions that can cause dysphonia in patients with systemic autoimmune diseases. The main question it aims to answer is: * What are the main cord vocal lesions responsible for dysphonia in patients with a systemic autoimmune disease? * Is there a diagnosis delay regarding those lesions? * How are those lesions managed? Participants suffering from dysphonia in a context of a systemic autoimmune disease will be identified, with a review of their medical record.
This description comes directly from the study's public registry record.
Alice TISON · 0298347264 · alice.tison@chu-brest.fr
Clément SARRAUSTE · 0298347264 · clement.sarrauste@chu-brest.fr
Always discuss trial participation with your own doctor first.
| Chu Brest | Brest, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06779799